Price movement over the last 24 hours
AdaptHealth Corp vs Super Micro Computer Inc — how do they compare? AdaptHealth Corp trades at $10.04 (market cap $1.38B), while Super Micro Computer Inc trades at $27.04 (market cap $16.98B). The key difference: Super Micro Computer Inc is far larger — about 12.3× AdaptHealth Corp's market cap, and AdaptHealth Corp is trading nearer its 52-week high, Super Micro Computer Inc nearer its low. Which is the better fit depends on your goals.
| AHCO | SMCI | |
|---|---|---|
Market Cap | $1.38B | $16.98B |
Sector | Health | Technology |
52-Week High | $13.38 | $60.71 |
52-Week Low | $8.68 | $20.53 |
Enterprise Value | $3.33B | $24.50B |
Signals from Pluang's Aura AI — not financial advice
AdaptHealth (AHCO) trades at $10.27, down 4.55% today, with neutral technical signals and mixed fundamental performance. The company reported Q1 2026 earnings miss with negative EPS of -$0.06 versus $0.0125 expected, continuing a pattern of recent quarterly misses. Despite revenue growth to $3.3B projected for 2026, net income remains negative with -2.43% margin. Analyst consensus remains bullish with 75% buy ratings and $14.80 price target, representing 44% upside potential from current levels.
The investment case balances strong analyst support and reasonable valuation (P/S 0.42, EV/EBITDA 7.17) against persistent profitability challenges. Recent refinancing improves financial flexibility, but execution on cost controls and margin improvement remains critical. The stock offers significant upside if management can translate revenue growth into sustainable profitability, though current negative earnings trend presents near-term headwinds.
Super Micro Computer (SMCI) trades at $27.19, down 0.11% with bearish technical signals. The stock faces headwinds from a Taiwan probe into alleged AI chip smuggling, contributing to recent volatility. Fundamentally, SMCI shows strong revenue growth with $22B in 2025 and $33.7B projected for 2026, though profit margins compressed from 4.77% to 3.7%. Valuation appears attractive with P/E of 14.31 and P/S of 0.54, while recent earnings beat expectations in two of the last three quarters.
The outlook remains cautious due to regulatory risks and negative technical momentum. Analyst consensus is mixed with 36% buy ratings and a $36.43 price target suggesting 34% upside. Key risks include the ongoing Taiwan investigation, competitive pressures in AI infrastructure, and cash flow volatility with projected negative operating cash flow in 2026. The stock presents a value opportunity but requires careful risk management.
Trailing returns across standard periods
Latest headlines on both assets
AdaptHealth provides patient-centered healthcare-at-home solutions in the U.S. It offers medical equipment and supplies for sleep therapy, respiratory health, diabetes management, and general home wellness.
Read more on AHCO →Super Micro Computer, Inc., commonly known as Supermicro, is a leading provider of high-performance and high-efficiency server technology and innovation. The company specializes in designing, manufacturing, and selling advanced server, storage, and networking solutions, primarily for data centers, cloud computing, artificial intelligence, and 5G/Edge computing markets. SMCI's modular architecture allows for the rapid delivery of customized and purpose-built solutions, making it a key player in the enterprise computing and specialized AI infrastructure space.
Read more on SMCI →